Are research peptides legal in the UK?

Yes: research peptides such as BPC-157, TB-500, GHK-Cu, Ipamorelin and retatrutide are legal to buy, sell, possess and use for laboratory research in the United Kingdom. They are not controlled substances under the Misuse of Drugs Act, and no licence is needed to purchase them for research. What the law does regulate is how they are sold and what they are sold for. This note gives a plain-English summary of the position for researchers and purchasing departments; it is general information, not legal advice. All Alphex products are for laboratory and in-vitro research only.

The short version

• Research peptides are legal to buy and possess in the UK for laboratory research.
• They are not licensed medicines. No product in the Alphex catalogue has a UK marketing authorisation, and it is unlawful for a supplier to sell or present them as medicines, or for any human or veterinary use.
• The regulatory framework that matters is the Human Medicines Regulations 2012 (what may be sold as a medicine and how it may be advertised), consumer protection law (accuracy of claims), and general chemical safety and postal rules.
• The compliant arrangement is a supplier selling to researchers for laboratory use, making no medicinal claims, with clear research-use-only labelling. That is how Alphex operates.

Why they are not controlled substances

The Misuse of Drugs Act 1971 and its schedules list specific controlled drugs and classes. Research peptides of this kind are not listed, and the Psychoactive Substances Act 2016 concerns substances with psychoactive effect, which these are not. Possession therefore requires no licence. This is different from, for example, anabolic steroids (Class C) or certain growth hormone preparations, and researchers should not assume all "performance" compounds sit in the same category. See UK research peptide compliance for the fuller framework.

Why they are not medicines

A product is a medicine in UK law if it is presented as treating or preventing disease, or if it is administered with a view to restoring, correcting or modifying physiological function. A research peptide sold as a laboratory reagent, with no such presentation and for no such purpose, is not a medicine and does not need a marketing authorisation. The same substance sold with claims about effects in people, or for administration to people, would be an unlicensed medicine and its sale a criminal offence. The line is drawn by presentation and purpose, which is why compliant suppliers are so careful about language. See the Human Medicines Regulations and research peptides.

What "research use only" means legally

It is the supplier's statement of the purpose for which the product is sold and the basis on which the sale is made. Ordering confirms that the buyer is purchasing for laboratory research and accepts responsibility for compliant use. It is not a loophole; it is the actual legal character of the transaction, and it is why the products may lawfully be sold at all. See research use only: what it means.

Practical points for buyers

• Universities, contract research organisations, companies and individual researchers may all purchase. See can universities and labs buy research peptides.
• Buying from a UK-stocked supplier avoids import questions entirely; importing from outside the UK is generally lawful for research use but involves customs declarations and occasional holds. See importing research peptides into the UK.
• Keep records: what was bought, from whom, batch number, for what project. See record keeping.
• Dispose of unused material as laboratory chemical waste. See disposal.

Frequently asked questions

Do I need to prove I am a researcher?

Alphex asks buyers to confirm research use at checkout and reserves the right to decline orders. There is no statutory licence to show.

Can a supplier be prosecuted for selling research peptides?

Not for selling them as research reagents. Suppliers have been prosecuted for selling them with medicinal claims or for human use, which is a different act.

Is the law the same in Scotland, Wales and Northern Ireland?

The Human Medicines Regulations 2012 and the Misuse of Drugs Act apply UK-wide.

Sources and further reading

• The Human Medicines Regulations 2012 (SI 2012/1916), legislation.gov.uk: the UK medicines framework; regulation 2 defines a medicinal product
• Misuse of Drugs Act 1971, legislation.gov.uk: the controlled-drugs schedules research peptides do not appear in
• Psychoactive Substances Act 2016, legislation.gov.uk
• MHRA: A guide to what is a medicinal product (Guidance Note 8), GOV.UK: how the MHRA decides whether a product is a medicine by presentation and function

This note is general information for researchers and is not legal advice. Alphex research peptides are supplied for laboratory and in-vitro research by qualified researchers only. They are not authorised for human or veterinary use.

Research use only. Alphex products are supplied exclusively for laboratory and in-vitro research by qualified researchers. They are not authorised for human or veterinary use, and nothing in this note is advice on any such use.

Published 10 June 2026, last reviewed 16 August 2026. Alphex reviews research notes when the testing method, the catalogue or UK guidance changes.

Alphex Research Team

Alphex Limited, UK research peptide supplier

The Alphex research team writes and maintains these notes for UK laboratories buying research peptides. Every batch Alphex lists is verified by reverse-phase HPLC with a batch-matched Certificate of Analysis. Content covers laboratory and in-vitro research only.